Designer drugs 2015: assessment and management

Designer drugs 2015: assessment and management

Mar 25, 2015 · Familiarity with designer drugs can help clinicians recognize common adverse reactions and life-threatening consequences. This article will focus on three newer designer drugs: substituted cathinones (commonly referred to as “bath salts”), synthetic cannabinoids (SCs; e.g., “Spice”), and synthetic hallucinogens (e.g., “N-bomb”).

Designer drugs 2015: assessment and management | Addiction

Routine inquiry about designer drug use is likely prudent, particularly among patients with a history of SUD, those who are undergoing mandated urine testing (e.g., criminal justice supervisees), or among those who have reported a history of designer drug use of a different chemical class . Different classes of designer drugs may be used concurrently, which could increase the incidence of adverse effects and …

[PDF]

Designer drugs 2015: assessment and management

REVIEW Open Access Designer drugs 2015: assessment and management Michael F Weaver1*, John A Hopper2 and Erik W Gunderson3 Abstract Recent designer drugs, also known as “legal highs,” include substituted cathinones (e.g., mephedrone, methylone,

(PDF) Designer drugs 2015: Assessment and management

Abuse of designer drugs is especially high among young adults, fre- quently leading to addiction, which can cause severe adverse effects and ultimately leading to economic burden, crimes and

Designer drugs 2015: assessment and management

TY – JOUR. T1 – Designer drugs 2015. T2 – Addiction science & clinical practice. AU – Weaver, Michael F. AU – Hopper, John A. AU – Gunderson, Erik W.

Stimulant and Designer Drug Use: Primary Care Management

Newer designer drugs such as synthetic cannabinoids and bath salts are not detected by routine drug screening.

Designer Drugs and the Impact on the Adolescent User

“Clinicians should keep designer drugs in mind when evaluating substance use in young adults or in anyone presenting with acute neuropsychiatric complaints. Treatment of acute intoxication involves supportive care targeting manifesting signs and symptoms” ( Weaver, Hopper, & Gunderson, 2015 ).

Publications related to Outside Publications | NDEWS l

Guidance on the Clinical Management of Acute and Chronic Harms of Club Drugs and Novel Psychoactive Substances.pdf Office of Quality, Planning & Research. (2015).

Weaver MF, Hopper JA, Gunderson EW. Designer drugs 2015

Moved Permanently. The document has moved here.

Designer Drugs – Assessment and Management | Mind Works

This course familiarizes users with designer drugs, known as “legal highs,” summarizes common effects of these drugs, and provides treatment recommendations. Objectives: a. Discuss the epidemiology of emerging designer drugs. b. Name at least one designer drug in each of the drug classes: stimulants, cannabinoids, and hallucinogens.

The New Designer Drug Wave: A Clinical, Toxicological, and

Schedule I classification indicates a drug has no currently accepted medical use and a high potential for abuse (Office of National Drug Control Policy 2015 Office of National Drug Control Policy. 2015. Synthetic drugs (a.k.a. K2, Spice, Bath Salts, etc.).

Published in: Journal of Psychoactive Drugs · 2015Authors: J D Ryan Abbott · E M D David SmithAffiliation: University of California Los AngelesAbout: Toxicity · Bath salts · Delirium · Amphetamine

Hallucinogens | Request PDF

We use cookies to make interactions with our website easy and meaningful, to better understand the use of our services, and to tailor advertising.

Designer Drugs: A Lethal High | Ciencia Puerto Rico

In the United States, around 200-300 new designer drugs were identified between 2009-2014. These drugs are often distributed in night clubs, parties, and raves. Aside from their many detrimental effects on the body, these drugs have an added danger and lethality.